|
NGLY1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.398500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.718100E-03 |
| Normal-vs-Stage2 |
2.675800E-02 |
| Normal-vs-Stage3 |
3.78020000000312E-05 |
| Normal-vs-Stage4 |
1.835310E-04 |
| Stage1-vs-Stage2 |
6.223400E-01 |
| Stage1-vs-Stage3 |
4.688200E-02 |
| Stage1-vs-Stage4 |
6.568200E-02 |
| Stage2-vs-Stage3 |
3.717600E-01 |
| Stage2-vs-Stage4 |
3.834400E-01 |
| Stage3-vs-Stage4 |
9.323800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.170500E-04 |
| Normal-vs-AfricanAmerican |
1.936080E-02 |
| Normal-vs-Asian |
1.274770E-01 |
| Caucasian-vs-AfricanAmerican |
9.397400E-01 |
| Caucasian-vs-Asian |
3.704000E-01 |
| AfricanAmerican-vs-Asian |
5.247800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.52710000000034E-05 |
| Normal-vs-Female |
1.084400E-03 |
| Male-vs-Female |
7.372000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.517600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.177580E-04 |
| Normal-vs-Age(61-80Yrs) |
1.188840E-04 |
| Normal-vs-Age(81-100Yrs) |
5.063400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.895800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.326000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.138200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.603000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.834600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.311600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.234360E-01 |
| Classical-VS-Follicular |
5.823400E-03 |
| Classical-VS-Other |
9.474100E-02 |
| Classical-VS-Normal |
1.464480E-02 |
| Tall-VS-Follicular |
5.531400E-01 |
| Tall-VS-Other |
4.004600E-01 |
| Tall-VS-Normal |
1.879800E-03 |
| Follicular-VS-Other |
6.741000E-01 |
| Follicular-VS-Normal |
5.90689999999672E-05 |
| Other-VS-Normal |
7.567900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.13809999999715E-05 |
| Normal-vs-N1 |
5.766100E-04 |
| N0-vs-N1 |
4.732400E-01 |
|
|
